FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201609934> ?p ?o ?g. }

• W3201609934 abstract "Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder characterized by combined immunodeficiency, eczema, microthrombocytopenia, autoimmunity, and lymphoid malignancies. Gene therapy (GT) to modify autologous CD34+ cells is an emerging alternative treatment with advantages over standard allogeneic hematopoietic stem cell transplantation for patients who lack well-matched donors, avoiding graft-versus-host-disease. We report the outcomes of a phase 1/2 clinical trial in which 5 patients with severe WAS underwent GT using a self-inactivating lentiviral vector expressing the human WAS complementary DNA under the control of a 1.6-kB fragment of the autologous promoter after busulfan and fludarabine conditioning. All patients were alive and well with sustained multilineage vector gene marking (median follow-up: 7.6 years). Clinical improvement of eczema, infections, and bleeding diathesis was universal. Immune function was consistently improved despite subphysiologic levels of transgenic WAS protein expression. Improvements in platelet count and cytoskeletal function in myeloid cells were most prominent in patients with high vector copy number in the transduced product. Two patients with a history of autoimmunity had flares of autoimmunity after GT, despite similar percentages of WAS protein-expressing cells and gene marking to those without autoimmunity. Patients with flares of autoimmunity demonstrated poor numerical recovery of T cells and regulatory T cells (Tregs), interleukin-10-producing regulatory B cells (Bregs), and transitional B cells. Thus, recovery of the Breg compartment, along with Tregs appears to be protective against development of autoimmunity after GT. These results indicate that clinical and laboratory manifestations of WAS are improved with GT with an acceptable safety profile. This trial is registered at clinicaltrials.gov as #NCT01410825." @default.
• W3201609934 created "2021-09-27" @default.
• W3201609934 creator A5003907179 @default.
• W3201609934 creator A5005825350 @default.
• W3201609934 creator A5012019419 @default.
• W3201609934 creator A5013184297 @default.
• W3201609934 creator A5013427760 @default.
• W3201609934 creator A5016101702 @default.
• W3201609934 creator A5016149531 @default.
• W3201609934 creator A5016535188 @default.
• W3201609934 creator A5017351450 @default.
• W3201609934 creator A5025599094 @default.
• W3201609934 creator A5029163913 @default.
• W3201609934 creator A5032021120 @default.
• W3201609934 creator A5032163287 @default.
• W3201609934 creator A5035721792 @default.
• W3201609934 creator A5039022189 @default.
• W3201609934 creator A5045404428 @default.
• W3201609934 creator A5056346259 @default.
• W3201609934 creator A5057197686 @default.
• W3201609934 creator A5057425979 @default.
• W3201609934 creator A5058418344 @default.
• W3201609934 creator A5061271832 @default.
• W3201609934 creator A5065312269 @default.
• W3201609934 creator A5066581132 @default.
• W3201609934 creator A5075501006 @default.
• W3201609934 creator A5079132405 @default.
• W3201609934 creator A5079214453 @default.
• W3201609934 creator A5082815899 @default.
• W3201609934 creator A5085906843 @default.
• W3201609934 date "2023-07-21" @default.
• W3201609934 modified "2023-10-13" @default.
• W3201609934 title "Outcomes of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome" @default.
• W3201609934 doi "https://doi.org/10.1182/blood.2022019117" @default.
• W3201609934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37478401" @default.
• W3201609934 hasPublicationYear "2023" @default.
• W3201609934 type Work @default.
• W3201609934 sameAs 3201609934 @default.
• W3201609934 citedByCount "3" @default.
• W3201609934 countsByYear W32016099342023 @default.
• W3201609934 crossrefType "journal-article" @default.
• W3201609934 hasAuthorship W3201609934A5003907179 @default.
• W3201609934 hasAuthorship W3201609934A5005825350 @default.
• W3201609934 hasAuthorship W3201609934A5012019419 @default.
• W3201609934 hasAuthorship W3201609934A5013184297 @default.
• W3201609934 hasAuthorship W3201609934A5013427760 @default.
• W3201609934 hasAuthorship W3201609934A5016101702 @default.
• W3201609934 hasAuthorship W3201609934A5016149531 @default.
• W3201609934 hasAuthorship W3201609934A5016535188 @default.
• W3201609934 hasAuthorship W3201609934A5017351450 @default.
• W3201609934 hasAuthorship W3201609934A5025599094 @default.
• W3201609934 hasAuthorship W3201609934A5029163913 @default.
• W3201609934 hasAuthorship W3201609934A5032021120 @default.
• W3201609934 hasAuthorship W3201609934A5032163287 @default.
• W3201609934 hasAuthorship W3201609934A5035721792 @default.
• W3201609934 hasAuthorship W3201609934A5039022189 @default.
• W3201609934 hasAuthorship W3201609934A5045404428 @default.
• W3201609934 hasAuthorship W3201609934A5056346259 @default.
• W3201609934 hasAuthorship W3201609934A5057197686 @default.
• W3201609934 hasAuthorship W3201609934A5057425979 @default.
• W3201609934 hasAuthorship W3201609934A5058418344 @default.
• W3201609934 hasAuthorship W3201609934A5061271832 @default.
• W3201609934 hasAuthorship W3201609934A5065312269 @default.
• W3201609934 hasAuthorship W3201609934A5066581132 @default.
• W3201609934 hasAuthorship W3201609934A5075501006 @default.
• W3201609934 hasAuthorship W3201609934A5079132405 @default.
• W3201609934 hasAuthorship W3201609934A5079214453 @default.
• W3201609934 hasAuthorship W3201609934A5082815899 @default.
• W3201609934 hasAuthorship W3201609934A5085906843 @default.
• W3201609934 hasConcept C104317684 @default.
• W3201609934 hasConcept C111599444 @default.
• W3201609934 hasConcept C126322002 @default.
• W3201609934 hasConcept C142669718 @default.
• W3201609934 hasConcept C1491633281 @default.
• W3201609934 hasConcept C203014093 @default.
• W3201609934 hasConcept C2776694085 @default.
• W3201609934 hasConcept C2776755627 @default.
• W3201609934 hasConcept C2777408962 @default.
• W3201609934 hasConcept C2777607303 @default.
• W3201609934 hasConcept C2778153459 @default.
• W3201609934 hasConcept C2779263901 @default.
• W3201609934 hasConcept C2780130043 @default.
• W3201609934 hasConcept C2780939953 @default.
• W3201609934 hasConcept C28328180 @default.
• W3201609934 hasConcept C2911091166 @default.
• W3201609934 hasConcept C2993400109 @default.
• W3201609934 hasConcept C54355233 @default.
• W3201609934 hasConcept C55493867 @default.
• W3201609934 hasConcept C71924100 @default.
• W3201609934 hasConcept C86803240 @default.
• W3201609934 hasConcept C8891405 @default.
• W3201609934 hasConcept C95444343 @default.
• W3201609934 hasConceptScore W3201609934C104317684 @default.
• W3201609934 hasConceptScore W3201609934C111599444 @default.
• W3201609934 hasConceptScore W3201609934C126322002 @default.
• W3201609934 hasConceptScore W3201609934C142669718 @default.
• W3201609934 hasConceptScore W3201609934C1491633281 @default.
• W3201609934 hasConceptScore W3201609934C203014093 @default.
• W3201609934 hasConceptScore W3201609934C2776694085 @default.
• W3201609934 hasConceptScore W3201609934C2776755627 @default.

• next